The London Stem Cell Network (LSCN) will be hosting its 5th Annual Symposium in collaboration with The Francis Crick Institute on the 25th of October 2022.
There will be a keynote presentation from Professor Christine Mummery, Leiden University Medical Center and a member of Mogrify’s Scientific Advisory Board, and a series of scientific talks and posters covering the breadth of stem cell research.
Mogrify is transforming the lives of patients through the development of a novel class of in vivo reprogramming therapies, initially addressing indications in ophthalmology, otology and metabolic and other areas of degenerative disease. Using its proprietary suite of platform technologies to systematically identify the key transcriptomic and epigenetic switches required to drive direct cellular reprogramming.
Connect with our team at the LSCN annual symposium.